Digging Up the Facts on MetLife, Inc. (MET)

MetLife, Inc. (MET) is an interesting player in the Financial space, with a focus on Life Insurance. The stock has been active on the tape, currently trading at $52.58, up from yesterday’s close by 0.11%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.

Fundamental Analysis

Does this stock stack up well when compared to its peers in the industry space? Let’s take a look. MetLife, Inc. (MET) currently trades with a market capitalization of $55.11 Billion.

The balance sheet health of any company plays a key role in its ability to meet its obligations and maintain the faith of its investment base. For MET, you can get a sense of how sustainable that is by a levered free cash flow of $14.07 Billion over the past twelve months. Generally speaking, earnings are expected to grow in coming quarters. Analysts are forecasting earnings of $0.97 on a per share basis this quarter. Perhaps, that suggests something about why 97.47% of the outstanding share supply is held by institutional investors.

Technical Analysis

It’s important to check the technicals to get a sense of how MET has been acting. Looking at the stock’s movement on the chart, MetLife, Inc. recorded a 52-week high of $52.73. It is now trading 0.15% off that level. The stock is trading $48.78 its 50-day moving average by -3.8%. The stock carved out a 52-week low down at $40.14.

In recent action, MetLife, Inc. (MET) has made a move of +12.33% over the past month, which has come on weak relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 17.45, and it’s gotten there by action that has been more volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 1.80% with $899.97 Million sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of MET.

Previous articleInovio Pharmaceuticals, Inc. (INO): What’s the Story?
Next articleChecking the Overall Picture for Gulfport Energy Corporation (GPOR)